Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
We have three comments about Pickup et al's meta-analysis
comparing insulin infusion with injection, which may cast a different
light on their main conclusion.1
Firstly, the results of the largest study in the meta-analysis, the so
called Dusseldorf study, needs careful interpretation. The authors have
estimated this study to show a positive result for continuous
subcutaneous insulin infusion, with an advantage in percentage of
glycated haemoglobin of 0.68%. This figure will be an estimation made
from a graph, as exact data are not given in the original paper. This
seems to be a correct interpretation of the six month data of this
study, but the total duration of the study was two years. At 12, 18, and 24 months the "advantage" of continuous subcutaneous insulin
infusion can be estimated to be 0.35%, -0.1%, and -0.2%,
respectively. Thus another interpretation of this one study,
representing 918 months of the meta-analysis's total of 2522 patient
Read all Rapid Responses